SE
Slifka Eric
Chairman & CEO
C-suiteM
Insider track record
CEOAcross 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Slifka Eric, Chairman & CEO. Insider active across 1 company, notably Global Partners LP. In total, 14 disclosures have been published. History available since 5 August 2021. The latest transaction was filed on 3 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
50,471 shares0Common units representing limited partner interestsSEC:0001062993-25-008622:0
24,802 shares0Common units representing limited partner interestsSEC:0001062993-25-006299:0
138,068 shares0Common units representing limited partner interestsSEC:0001062993-25-003929:0
21,459 shares0Common units representing limited partner interestsSEC:0001062993-25-000519:0
23,010 shares0Common units representing limited partner interestsSEC:0001062993-25-000167:0
350,000 shares0Common units representing limited partner interestsSEC:0001062993-24-007134:0
14,501 shares0Common units representing limited partner interestsSEC:0001062993-24-004942:0
21,459 shares0Common units representing limited partner interestsSEC:0001062993-24-000707:0
23,012 shares0Common units representing limited partner interestsSEC:0001062993-24-000210:0
38,940 shares0Common units representing limited partner interestsSEC:0001062993-23-017378:0
23,012 shares0Common units representing limited partner interestsSEC:0001062993-23-000661:0
65,512 shares0Common units representing limited partner interestsSEC:0001062993-22-017349:0
57,323 shares0Common units representing limited partner interestsSEC:0001323468-21-000038:0
57,323 shares0Common units representing limited partner interestsSEC:0001323468-21-000038
About Slifka Eric
Eric Slifka is Vice Chairman, President, and CEO of GLOBAL PARTNERS LP. He leads the company by ensuring its strategic development and market performance. His leadership is pivotal to the success of GLOBAL PARTNERS.